Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Liang, Yu ^a,b   Bollen, Andrew W ^c   Aldape, Ken D ^d   Gupta, Nalin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b APPLIED BIOSYSTEMS   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 7; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTROCYTE; ASTROCYTOMA; BRAIN TISSUE; CANCER INFILTRATION; CANCER SURVIVAL; CELL MIGRATION; CELL NUCLEUS; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DATA ANALYSIS; DISEASE COURSE; DNA MICROARRAY; GENE OVEREXPRESSION; GLIA; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MOLECULAR MECHANICS; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TUMOR CELL; TUMOR CELL LINE;

ASTROCYTES; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; COHORT STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GLIOMA; HUMANS; LIFE TABLES; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SUBCELLULAR FRACTIONS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 33745071151     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-97     Document Type: Article

References (38)

1. Medical Research Council Brain Tumor Working Party: Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical. Research Council trial. J Clin Oncol 2001, 19(2):509-518.
2. Korkolopoulou P, Christodoulou P, Kouzelis K, Hadjiyannakis M, Priftis A, Stamoulis G, Seretis A, Thomas-Tsagli E: MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor. Br J Cancer 1997, 75(9):1269-1278.
3. Etienne MC, Formento JL, Lebrun-Frenay C, Gioanni J, Chatel M, Paquis P, Bernard C, Courdi A, Bensadoun RJ, Pignol JP, Francoual M, Grellier P, Frenay M, Milano G: Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome. Clin Cancer Res 1998, 4(10):2383-2390.
4. Rainov NG, Dobberstein KU, Bahn H, Holzhausen HJ, Lautenschlager C, Heidecke V, Burkert W: Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumor-suppressor gene products on survival. J Neurooncol 1997, 35(1):13-28.
5. Waha A, Baumann A, Wolf HK, Fimmers R, Neumann J, Kindermann D, Astrahantseff K, Blumcke I, von Deimling A, Schlegel U: Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas. J Neurosurg 1996, 85(4):634-641.
6. Newcomb EW, Cohen H, Lee SR, Bhalla SK, Bloom J, Hayes RL, Miller DC: Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGER, MDM2 or Bcl-2 genes. Brain Pathol 1998, 8(4):655-667.
7. Simmons ML, Lamborn KR, Takahashi M, Chen P, Israel MA, Berger MS, Godfrey T, Nigro J, Prados M, Chang S, Barker FG 2nd, Aldape K: Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res 2001, 61(3):1122-1128.
8. Batchelor TT, Betensky RA, Esposito JM, Pham LD, Dorfman MV, Piscatelli N, Jhung S, Rhee D, Louis DN: Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin Cancer Res 2004, 10(1 Pit 1):228-233.
9. Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK, Lamborn KR, Berger MS, Botstein D, Brown PO, Israel MA. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A 2005, 102(16):5814-5819.
10. Diehn M, Sherlock G, Binkley G, Jin H, Matese JC, Hernandez-Boussard T, Rees CA, Cherry JM, Botstein D, Brown PO, Alizadeh AA: SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res 2003, 31(1):219-223.
11. Feng L, Hatten ME, Heintz N: Brain lipid-binding protein (BLBP): a novel signaling system in the developing mammalian CNS. Neuron 1994, 12(4):895-908.
12. Godbout R, Bisgrove DA, Shkolny D, Day RS 3rd: Correlation of B-FABP and GFAP expression in malignant glioma. Oncogene 1998, 16(15):1955-1962.
13. Miller SJ, Li H, Rizvi TA, Huang Y, Johansson G, Bowersock J, Sidani A, Vitullo J, Vogel K, Parysek LM, DeClue JE, Ratner N: Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis. Mol Cell Biol 2003, 23(6):2213-2224.
14. Owada Y, Yoshimoto T, Kondo H: Increased expression of the mRNA for brain- and skin-type but not heart-type fatty acid binding proteins following kainic acid systemic administration in the hippocampal glia of adult rats. Brain Res Mol Brain Res 1996, 42(1):156-160.
15. Xu LZ, Sanchez R, Sali A, Heintz N: Ligand specificity of brain lipid-binding protein. JBiol Chem 1996, 271(40):24711-24719.
16. Feng L, Heintz N: Differentiating neurons activate transcription of the brain lipid-binding protein gene in radial glia through a novel regulatory element. Development 1995, 121(6):1719-1730.
17. Shimizu F, Watanabe TK, Shinomiya H, Nakamura Y, Fujiwara T. Isolation and expression of a cDNA for human brain fatty acid-binding protein (B-FABP). Biochim Biophys Acta 1997, 1354(1):24-28.
18. Khan SH, Sorof S: Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators. Proc Natl Acad Sci U S A 1994, 91(3):848-852.
19. Shi YE, Ni J, Xiao G, Liu YE, Fuchs A, Yu G, Su J, Cosgrove JM, Xing L, Zhang M, Li J, Aggarwal BB, Meager A, Gentz R: Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG. Cancer Res 1997, 57(15):3084-3091.
20. Wang M, Liu YE, Ni J, Aygun B, Goldberg ID, Shi YE: Induction of mammary differentiation by mammary-derived growth inhibitor-related gene that interacts with an omega-3 fatty acid on growth inhibition of breast cancer cells. Cancer Res 2000, 60(22):6482-6487.
21. Glatz JF, Luiken JJ, van Bilsen M, van der Vusse GJ: Cellular lipid binding proteins as facilitators and regulators of lipid metabolism. Mol Cell Biochem 2002, 239(1-2):3-7.
22. Wolfrum C, Borrmann CM, Borchers T, Spener F: Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc Natl Acad Sci U S A 2001, 98(5):2323-2328.
23. Huang H, Starodub O, McIntosh A, Kier AB, Schroeder F: Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells. J Biol Chem 2002, 277(32):29139-29151.
24. Huang H, Starodub O, McIntosh A, Atshaves BP, Woldegiorgis G, Kier AB, Schroeder F: Liver fatty acid-binding protein colocalizes with peroxisome proliferator activated receptor alpha and enhances ligand distribution to nuclei of living cells. Biochemistry 2004, 43(9):2484-2500.
25. Abdelwahab SA, Owada Y, Kitanaka N, Iwasa H, Sakagami H, Kondo H: Localization of brain-type fatty acid-binding protein in Kupffer cells of mice and its transient decrease in response to lipopolysaccharide. Histochem Cell Biol 2003, 119(6):469-475.
26. Sonoda Y, Ozawa T, Hirose Y, Aldape KD, McMahon M, Berger MS, Pieper RO: Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res 2001, 61(13):4956-4960.
27. Kurtz A, Zimmer A, Schnutgen F, Bruning G, Spener F, Muller T: The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development. Development 1994, 120(9):2637-2649.
28. Gutmann DH, Hedrick NM, Li J, Nagarajan R, Perry A, Watson MA: Comparative gene expression profile analysis of neurofibromatosis I-associated and sporadic pilocytic astrocytomas. Cancer Res 2002, 62(7):2085-2091.
29. Nigro JM, Misra A, Zhang L, Smirnov I, Colman H, Griffin C, Ozburn N, Chen M, Pan E, Koul D, Yung WK, Feuerstein BG, Aldape KD: Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res 2005, 65(5):1678-1686.
30. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN: Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003, 63(7):1602-1607.
31. Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD, Laerum OD: Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res 1990, 50(18):6039-6044.
32. Das R, Hammamieh R, Neill R, Melhem M, Jett M: Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues. Clin Cancer Res 2001, 7(6):1706-1715.
33. Shinojima N, Tada K, Shiraishi S, Kamiryo T, Kochi M, Nakamura H, Makino K, Saya H, Hirano H, Kuratsu J, Oka K, Ishimaru Y, Ushio Y: Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res 2003, 63(20):6962-6970.
34. Shoshan Y, Nishiyama A, Chang A, Mork S, Barnett GH, Cowell JK, Trapp BD, Staugaitis SM: Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors. Proc Natl Acad Sci U S A 1999, 96(18):10361-1036.
35. Nishiyama A, Chang A, Trapp BD: NG2+ glial cells: a novel glial cell population in the adult brain. J Neuropathol Exp Neurol 1999, 58(11):1113-1124.
36. Liang Y, Bollen AW, Nicholas K, Gupta N: Id4 and FABP7 are preferentially expressed in cells with astrocytic features in oligodendrogliomas and oligoastrocytomas. BMC Clin Pathol 2005, 5(1):6.
37. Wunderlich MT, Hanhoff T, Goertler M, Spener F, Glatz JF, Wallesch CW, Pelsers MM: Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke. J Neurol 2005, 252(6):718-724.
38. de Wit NJ, Rijntjes J, Diepstra JH, van Kuppevelt TH, Weidle UH, Ruiter DJ, van Muijen GN: Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays. Br J Cancer 2005, 92(12):2249-2261.